Abstract
Synthetic surfactant peptides offer an opportunity to standardize the protein composition of surfactant. We tested the effect of phospholipids (PL) with synthetic full-length SP-B1-78 (B), mutant B (Bser), KL4 peptide (UCLA-KL4), and palmitoylated SP-C1-35 (C) on oxygenation and lung function in a surfactant-deficient rat model. Sixty-four adult rats were ventilated with 100% oxygen, a tidal volume of 7.5 mL/kg, and a rate of 60/min. Their lungs were lavaged with saline until the arterial PO2 dropped below 80 torr, when 100 mg/kg surfactant was instilled. Surfactant preparations included: PL (PL surfactant), PL + 3% B (B surfactant), PL + 3% B and 1% C (BC surfactant), PL + 3% UCLA-KL4(KL4 surfactant), PL + 3% Bser (Bser surfactant), and PL + 3% B and 1% UCLA-KL4 (BKL4 surfactant). Sixty minutes after surfactant instillation, positive end-expiratory pressure was applied for 5 min, and pressure-volume curves were determined in situ. The six surfactant preparations had a minimum surface tensions <10 mN/m on a Langmuir/Wilhelmy balance. Instillation of PL, Bser, and BKL4 surfactant increased mean arterial/alveolar PO2 (aADO2) ratios by 50-100% over postlavage values, whereas KL4 surfactant increased aADO2 ratios by 118%, B surfactant by 191%, and BC surfactant by 225%. Lung volumes at 30 cm H2O pressure were highest after treatment with BC surfactant, intermediate after B and KL4 surfactants, and lowest after BKL4, Bser, and PL surfactants. These data suggest that a surfactant preparation with a combination of synthetic B and C peptides surpasses synthetic B and KL4 surfactants in improving oxygenation and lung compliance in surfactant-deficient rats.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- aADO2:
-
arterial/alveolar PO2 ratio
- DPPC:
-
dipalmitoyl phosphatidylcholine
- FIO2:
-
fraction of inspired O2
- PA:
-
palmitic acid
- Pao:
-
arterial partial pressure of O2
- PaCO2:
-
arterial arterial partial pressure of CO2
- PEEP:
-
positive end-expiratory pressure
- PL:
-
phospholipid
- POPG:
-
1-palmitoyl-2-oleoyl phosphatidyl glycerol
- SP:
-
surfactant protein
- PG:
-
phosphatidyl glycerol
- Fmoc:
-
N-(9-fluorenyl)methoxycarbonyl
References
McLean LR, Lewis JE, Hagaman KA, Owen TJ, Jackson RL 1993 Amphipathichelical peptides based on surfactant apoprotein SP-A. Biochim Biophys Acta 1166: 31–38.
Waring A, Taeusch W, Bruni R, Amirkhanian J, Fan B, Stevens R, Young J 1989 Synthetic amphipathic sequences of surfactant protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins. Pept Res 2: 308–313.
Bruni R, David-Cu R, Navar C, Waring AJ, Fan BR, Taeusch HW 1994 Effects of acylation on structural and functional properties of a synthetic replica of surfactant protein C. In: Cosmi EV, Di Renzo GC (eds) Current Progress in Perinatal Medicine. Parthenon, New York, PP 869–875.
Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA 1996 Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 93: 9594–9599.
Nogee LM, de Mello DE, Dehner LP, Colten HR 1993 Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 328: 406–410.
Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR 1994 A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93: 1860–1863.
Hamvas A, Nogee LM, Mallory GB . Spray TL, Huddleston CB, August A, Dehner LP, deMello DE, Moxley M, Nelson R, Cole FS, Colten HR 1997 Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 130: 231–239.
Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH 1992 Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 145: 24–30.
van Eijk M, deHass CGH CGH, Haagsman HP 1995 Quantitative analysis of pulmonary surfactant proteins B and C. Anal Biochem 232: 231–237.
Seeger W, Grube C, Günther A, Schmidt R 1993 Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6: 971–977.
Gustafsson M, Vandenbussche G, Curstedt T, Ruysschaert JM, Johansson J 1996 The 21-residue surfactant peptide (LysLeu4)4Lys(KL4) is a transmembrane α-helix with a mixed nonpolar/polar surface. FEBS Lett 384: 185–188.
Fields CG, Loyd DH, McDonald RL, Ottenson KM, Nobel RL 1991 HBTU activation for automated Fmoc solid-phase peptide synthesis. Pept Res 4: 95–101.
Lipp MM, Lee KYC, Zasadzinski JA, Waring AJ 1996 Phase and morphology changes in lipid monolayers induced by SP-B protein and its amino terminal peptide. Science 273: 1196–1199.
Ellman GL 1959 Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70–77.
Pace NC, Vajdos F, Fee L, Grimsley G, Gray T 1995 How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4: 2411–2423.
Goormaghtigh E, Cabiaux V, Ruysschaert J-M 1990 Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem 193: 409–420.
Gordon LM, Horvath S, Longo M, Zasadzinski JAN, Taeusch HW, Faull K, Leung C, Waring AJ 1996 Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci 5: 1662–1675.
Lapidot Y, Rappoport S, Wolman Y 1967 Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids. J Lipid Res 8: 142–145.
Revak SD, Merritt TA, Hallman M, Heldt G, La Polla RJ, Hoey K, Houghten RA, Cochrane CG 1991 The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr Res 29: 460–465.
Cochrane CG, Revak SD 1991 Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 254: 566–568.
Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD, Easa D, Pramanik A, Edwards DK, Alberts MS 1996 The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am J Respir Crit Care Med 153: 404–410.
Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A 1996 Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr Res 39: 715–724.
Tanaka Y, Takei T, Aiba T, Masuda K, Kiuchi A, Fujiwara T 1986 Development of synthetic lung surfactants. J Lipid Res 27: 475–485.
Longo ML, Bisagno AM, Zasadzinski JAN, Bruni R, Waring AJ 1993 The function of lung surfactant protein SP-B. Science 261: 453–456.
Walther FJ, David-Cu R, Leung C, Bruni R, Hernandez-Juviel J, Gordon LM, Waring AJ 1996 A synthetic segment of surfactant protein A: structure, in vitro surface activity, and in vivo efficacy. Pediatr Res 39: 938–946.
Holm BA, Wang Z, Egan EA, Notter RH 1996 Content of dipalmitoyl phosphatidyl-choline in lung surfactant: ramifications for surface activity. Pediatr Res 39: 805–811.
Rider ED, Ikegami M, Whitsett JA, Hull W, Absolom D, Jobe AH 1993 Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits. Am Rev Respir Dis 147: 669–676.
Holm BA, Waring AJ 1993 Designer surfactants. The next generation in surfactant replacement. Clin Perinatol 20: 813–829.
Walther FJ, Hernandez-Juviel J, Bruni R, Waring AJ 1997 Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats. Am J Respir Crit Care Med 156: 855–861.
Bruni R, Taeusch HW, Waring AJ 1991 Surfactant protein SP-B: lipid interactions of synthetic peptides representing the amino terminal amphipathic domain. Proc Natl Acad Sci USA 88: 7451–7455.
Kobayashi T, Kataoka H, Ueda T, Murakami S, Takada Y, Kukubo M 1984 Effects of surfactant supplement and end-expiratory pressure in lung-lavaged rabbits. J Appl Physiol 57: 995–1001.
Rider ED, Jobe AH, Ikegami M, Sun B 1992 Different ventilation strategies alter surfactant responses in preterm rabbits. J Appl Physiol 73: 2089–2096.
Merritt TA, Kheiter A, Cochrane CG 1995 Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome. Pediatr Res 38: 211–217.
Author information
Authors and Affiliations
Additional information
Supported by Grant HL55534 from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Walther, F., Hernández-Juviel, J., Bruni, R. et al. Protein Composition of Synthetic Surfactant Affects Gas Exchange in Surfactant-Deficient Rats. Pediatr Res 43, 666–673 (1998). https://doi.org/10.1203/00006450-199805000-00016
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199805000-00016
